Sign up to save your podcasts
Or
Share Science News: Antipsychotics and Cancer, Screening for Depression, and Alzheimer's Drug Controversy
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Science News: Antipsychotics and Cancer, Screening for Depression, and Alzheimer's Drug Controversy
This week, Peter Simons covers a study that found prolactin-increasing antipsychotics associated with increased breast cancer risk, an analysis that found no convincing evidence that screening for depression improves outcomes, and the continuing controversy around the FDA's approval of Biogen's failed Alzheimer's drug aducanumab.
- Antipsychotics Linked to Increased Breast Cancer Risk
- Screening for Depression in Primary Care Does Not Improve Outcomes
- Alzheimer’s Drug Controversy Continues
View all episodes
By Mad in America
5
1010 ratings
This week, Peter Simons covers a study that found prolactin-increasing antipsychotics associated with increased breast cancer risk, an analysis that found no convincing evidence that screening for depression improves outcomes, and the continuing controversy around the FDA's approval of Biogen's failed Alzheimer's drug aducanumab.
- Antipsychotics Linked to Increased Breast Cancer Risk
- Screening for Depression in Primary Care Does Not Improve Outcomes
- Alzheimer’s Drug Controversy Continues
More shows like Mad in America: Science News
View all
Mad in America: Rethinking Mental Health
160 Listeners
Birgit inviterer
1 Listeners
Mad in Ireland: Fields of Healing
2 Listeners
GALET - om psykisk hälsa och välbefinnande i en ny tid
0 Listeners
Luomupsykiatriaa - Aku ja Ben
0 Listeners